1 |
Goekoop-Ruiterman, Y. P., J. K. de Vries-Bouwstra, C. F. Allaart, Z. D. van, P. J. Kerstens, J. M. Hazes, A. H. Zwinderman, H. K. Ronday, K. H. Han, M. L. Westedt, A. H. Gerards, J. H. van Groenendael, W. F. Lems, M. V. van Krugten, F. C. Breedveld, and B. A. Dijkmans. 2005. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial. Arthritis Rheum. 52: 3381-3390.
DOI
|
2 |
Pincus, T., G. Ferraccioli, T. Sokka, A. Larsen, R. Rau, I. Kushner, and F. Wolfe. 2002. Evidence from clinical trials and long-term observational studies that disease-modifying anti-rheumatic drugs slow radiographic progression in rheumatoid arthritis: updating a 1983 review. Rheumatology (Oxford) 41: 1346-1356.
DOI
|
3 |
Aletaha, D., and J. S. Smolen. 2002. The rheumatoid arthritis patient in the clinic: comparing more than 1,300 consecutive DMARD courses. Rheumatology (Oxford) 41: 1367-1374.
DOI
|
4 |
Emery, P., F. C. Breedveld, M. Dougados, J. R. Kalden, M. H. Schiff, and J. S. Smolen. 2002. Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide. Ann. Rheum. Dis. 61: 290-297.
DOI
|
5 |
Prevoo, M. L., M. A. van 't Hof, H. H. Kuper, M. A. van Leeuwen, L. B. van de Putte, and P. L. van Riel. 1995. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 38: 44-48.
DOI
|
6 |
van der Heijde, D. 2000. How to read radiographs according to the Sharp/van der Heijde method. J. Rheumatol. 27: 261-263.
|
7 |
Katano, M., K. Okamoto, M. Arito, Y. Kawakami, M. S. Kurokawa, N. Suematsu, S. Shimada, H. Nakamura, Y. Xiang, K. Masuko, K. Nishioka, K. Yudoh, and T. Kato. 2009. Implication of granulocyte-macrophage colony-stimulating factor induced neutrophil gelatinase-associated lipocalin in pathogenesis of rheumatoid arthritis revealed by proteome analysis. Arthritis Res. Ther. 11: R3.
DOI
|
8 |
Schulz, M., H. Dotzlaw, S. Mikkat, M. Eggert, and G. Neeck. 2007. Proteomic analysis of peripheral blood mononuclear cells: selective protein processing observed in patients with rheumatoid arthritis. J. Proteome Res. 6: 3752-3759.
DOI
|
9 |
Lu, M. C., N. S. Lai, H. C. Yu, H. B. Huang, S. C. Hsieh, and C. L. Yu. 2010. Anti-citrullinated protein antibodies bind surface-expressed citrullinated Grp78 on monocyte/macrophages and stimulate tumor necrosis factor alpha production. Arthritis Rheum. 62: 1213-1223.
DOI
|
10 |
Tilleman, K., B. K. Van, A. Dhondt, I. Hoffman, K. F. De, E. Veys, D. Elewaut, and D. Deforce. 2005. Chronically inflamed synovium from spondyloarthropathy and rheumatoid arthritis investigated by protein expression profiling followed by tandem mass spectrometry. Proteomics 5: 2247-2257.
DOI
|
11 |
Watanabe, J., C. Charles-Schoeman, Y. Miao, D. Elashoff, Y. Y. Lee, G. Katselis, T. D. Lee, and S. T. Reddy. 2012. Proteomic profiling following immunoaffinity capture of high-density lipoprotein: association of acute-phase proteins and complement factors with proinflammatory high-density lipoprotein in rheumatoid arthritis. Arthritis Rheum. 64: 1828-1837.
DOI
|
12 |
Mallick, P., and B. Kuster. 2010. Proteomics: a pragmatic perspective. Nat. Biotechnol. 28: 695-709.
DOI
|
13 |
Wilkins, M. R., C. Pasquali, R. D. Appel, K. Ou, O. Golaz, J. C. Sanchez, J. X. Yan, A. A. Gooley, G. Hughes, I. Humphery- Smith, K. L. Williams, and D. F. Hochstrasser. 1996. From proteins to proteomes: large scale protein identification by two-dimensional electrophoresis and amino acid analysis. Biotechnology (N.Y.) 14: 61-65.
DOI
|
14 |
Anderson, N. L., and N. G. Anderson. 1998. Proteome and proteomics: new technologies, new concepts, and new words. Electrophoresis 19: 1853-1861.
DOI
|
15 |
Blackstock, W. P., and M. P. Weir. 1999. Proteomics: quantitative and physical mapping of cellular proteins. Trends Biotechnol. 17: 121-127.
DOI
|
16 |
Ryu, S. Y. 2014. Bioinformatics tools to identify and quantify proteins using mass spectrometry data. Adv. Protein Chem. Struct. Biol. 94: 1-17.
DOI
|
17 |
Kim, S. J., S. Chae, H. Kim, D. G. Mun, S. Back, H. Y. Choi, K. S. Park, D. Hwang, S. H. Choi, and S. W. Lee. 2014. A protein profile of visceral adipose tissues linked to early pathogenesis of type 2 diabetes mellitus. Mol. Cell. Proteomics. 13: 811-822.
DOI
|
18 |
Wilhelm, M., J. Schlegl, H. Hahne, G. A. Moghaddas, M. Lieberenz, M. M. Savitski, E. Ziegler, L. Butzmann, S. Gessulat, H. Marx, T. Mathieson, S. Lemeer, K. Schnatbaum, U. Reimer, H. Wenschuh, M. Mollenhauer, J. Slotta-Huspenina, J. H. Boese, M. Bantscheff, A. Gerstmair, F. Faerber, and B. Kuster. 2014. Mass-spectrometry-based draft of the human proteome. Nature 509: 582-587.
DOI
|
19 |
Farrah, T., E. W. Deutsch, G. S. Omenn, D. S. Campbell, Z. Sun, J. A. Bletz, P. Mallick, J. E. Katz, J. Malmstrom, R. Ossola, J. D. Watts, B. Lin, H. Zhang, R. L. Moritz, and R. Aebersold. 2011. A high-confidence human plasma proteome reference set with estimated concentrations in PeptideAtlas. Mol. Cell. Proteomics. 10: M110.006353
DOI
|
20 |
Smolen, J. S., and D. Aletaha. 2004. Patients with rheumatoid arthritis in clinical care. Ann. Rheum. Dis. 63: 221-225.
DOI
|
21 |
Wolfe, F., K. Michaud, O. Gefeller, and H. K. Choi. 2003. Predicting mortality in patients with rheumatoid arthritis. Arthritis Rheum. 48: 1530-1542.
DOI
|
22 |
Pincus, T., L. F. Callahan, W. G. Sale, A. L. Brooks, L. E. Payne, and W. K. Vaughn. 1984. Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. Arthritis Rheum. 27: 864-872.
DOI
|
23 |
Sokka, T., and P. Hannonen. 2000. Healing of erosions in rheumatoid arthritis. Ann. Rheum. Dis. 59: 647-649.
DOI
|
24 |
Rau, R., S. Wassenberg, G. Herborn, W. T. Perschel, and G. Freitag. 2001. Identification of radiologic healing phenomena in patients with rheumatoid arthritis. J. Rheumatol. 28: 2608-2615.
|
25 |
van der, H. D., and R. Landewe. 2003. Imaging: do erosions heal? Ann. Rheum. Dis. 62 Suppl 2: ii10-ii12.
DOI
|
26 |
Ideguchi, H., S. Ohno, H. Hattori, A. Senuma, and Y. Ishigatsubo. 2006. Bone erosions in rheumatoid arthritis can be repaired through reduction in disease activity with conventional disease- modifying antirheumatic drugs. Arthritis Res. Ther. 8: R76.
DOI
|
27 |
Arnett, F. C., S. M. Edworthy, D. A. Bloch, D. J. McShane, J. F. Fries, N. S. Cooper, L. A. Healey, S. R. Kaplan, M. H. Liang, H. S. Luthra, T. A. Medsger Jr, D. M. Mitchell, D. H. Neustadt, R. S. Pinals, J. G. Schaller, J. T. Sharp, R. L. Wilder and G. G. Hunder. 1988. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31: 315-324.
DOI
|
28 |
Boja, E. S., and H. Rodriguez. 2012. Mass spectrometry-based targeted quantitative proteomics: achieving sensitive and reproducible detection of proteins. Proteomics 12: 1093-1110.
DOI
|
29 |
Rigaut, G., A. Shevchenko, B. Rutz, M. Wilm, M. Mann, and B. Seraphin. 1999. A generic protein purification method for protein complex characterization and proteome exploration. Nat. Biotechnol. 17: 1030-1032.
DOI
|
30 |
Venne, A. S., L. Kollipara, and R. P. Zahedi. 2014. The next level of complexity: crosstalk of posttranslational modifications. Proteomics 14: 513-524.
DOI
|
31 |
Johnson, H., and C. E. Eyers. 2010. Analysis of post-translational modifications by LC-MS/MS. Methods Mol. Biol. 658: 93-108.
DOI
|
32 |
Konermann, L., J. Pan, and Y. H. Liu. 2011. Hydrogen exchange mass spectrometry for studying protein structure and dynamics. Chem. Soc. Rev. 40: 1224-1234.
DOI
|
33 |
Zhang, Z., H. Pan, and X. Chen. 2009. Mass spectrometry for structural characterization of therapeutic antibodies. Mass Spectrom. Rev. 28: 147-176.
DOI
|
34 |
Tilleman, K., and D. Deforce. 2008. Proteomics in rheumatology. Expert Rev. Proteomics 5: 755-759.
DOI
|
35 |
Dasuri, K., M. Antonovici, K. Chen, K. Wong, K. Standing, W. Ens, H. El-Gabalawy, and J. A. Wilkins. 2004. The synovial proteome: analysis of fibroblast-like synoviocytes. Arthritis Res. Ther. 6: R161-R168.
DOI
|
36 |
Li, X. J., M. Xu, X. Q. Zhao, J. N. Zhao, F. F. Chen, W. Yu, D. Y. Gao, and B. Luo. 2013. Proteomic analysis of synovial fibroblast-like synoviocytes from rheumatoid arthritis. Clin. Exp. Rheumatol. 31: 552-558.
|
37 |
Boers, M., A. C. Verhoeven, H. M. Markusse, M. A. van de Laar, R. Westhovens, J. C. van Denderen, Z. D. van, B. A. Dijkmans, A. J. Peeters, P. Jacobs, H. R. van den Brink, H. J. Schouten, D. M. van der Heijde, A. Boonen, and S. van der Linden. 1997. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet 350: 309-318.
DOI
|
38 |
Aletaha, D., T. Neogi, A. J. Silman, J. Funovits, D. T. Felson, C. O. Bingham, III, N. S. Birnbaum, G. R. Burmester, V. P. Bykerk, M. D. Cohen, B. Combe, K. H. Costenbader, M. Dougados, P. Emery, G. Ferraccioli, J. M. Hazes, K. Hobbs, T. W. Huizinga, A. Kavanaugh, J. Kay, T. K. Kvien, T. Laing, P. Mease, H. A. Menard, L. W. Moreland, R. L. Naden, T. Pincus, J. S. Smolen, E. Stanislawska-Biernat, D. Symmons, P. P. Tak, K. S. Upchurch, J. Vencovsky, F. Wolfe, and G. Hawker. 2010. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann. Rheum. Dis. 69: 1580-1588.
DOI
|
39 |
Harrison, B. J., D. P. Symmons, E. M. Barrett, and A. J. Silman 1998. The performance of the 1987 ARA classification criteria for rheumatoid arthritis in a population based cohort of patients with early inflammatory polyarthritis. American Rheumatism Association. J. Rheumatol. 25: 2324-2330.
|
40 |
Machold, K. P., T. A. Stamm, G. J. Eberl, V. K. Nell, A. Dunky, M. Uffmann, and J. S. Smolen. 2002. Very recent onset arthritis--clinical, laboratory, and radiological findings during the first year of disease. J. Rheumatol. 29: 2278-2287.
|
41 |
Liao, H., J. Wu, E. Kuhn, W. Chin, B. Chang, M. D. Jones, S. O'Neil, K. R. Clauser, J. Karl, F. Hasler, R. Roubenoff, W. Zolg, and B. C. Guild. 2004. Use of mass spectrometry to identify protein biomarkers of disease severity in the synovial fluid and serum of patients with rheumatoid arthritis. Arthritis Rheum. 50: 3792-3803.
DOI
|
42 |
Yoo, S. A., S. You, H. J. Yoon, D. H. Kim, H. S. Kim, K. Lee, J. H. Ahn, D. Hwang, A. S. Lee, K. J. Kim, Y. J. Park, C. S. Cho, and W. U. Kim. 2012. A novel pathogenic role of the ER chaperone GRP78/BiP in rheumatoid arthritis. J. Exp. Med. 209: 871-886.
DOI
|
43 |
Van Riel PL, W. M., van de Putte LB. 1998. Evaluation and management of active inflammatory disease. In Rheumatology, 2nd ed. D. P. Klippel JH, ed. Mosby, London. p. 5.14.11-13.
|
44 |
Kang, M. J., Y. J. Park, S. You, S. A. Yoo, S. Choi, D. H. Kim, C. S. Cho, E. C. Yi, D. Hwang, and W. U. Kim. 2014. Urinary proteome profile predictive of disease activity in rheumatoid arthritis. J. Proteome. Res. 13: 5206-5217.
DOI
|
45 |
Smolen, J. S., R. Landewe, F. C. Breedveld, M. Buch, G. Burmester, M. Dougados, P. Emery, C. Gaujoux-Viala, L. Gossec, J. Nam, S. Ramiro, K. Winthrop, W. M. de, D. Aletaha, N. Betteridge, J. W. Bijlsma, M. Boers, F. Buttgereit, B. Combe, M. Cutolo, N. Damjanov, J. M. Hazes, M. Kouloumas, T. K. Kvien, X. Mariette, K. Pavelka, P. L. van Riel, A. Rubbert-Roth, M. Scholte-Voshaar, D. L. Scott, T. Sokka-Isler, J. B. Wong, and D. van der Heijde. 2014. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann. Rheum. Dis. 73: 492-509.
|
46 |
Mewar, D., and A. G. Wilson. 2011. Treatment of rheumatoid arthritis with tumour necrosis factor inhibitors. Br. J. Pharmacol. 162: 785-791.
DOI
|
47 |
Jin, E. H., S. C. Shim, H. G. Kim, S. C. Chae, and H. T. Chung. 2009. Polymorphisms of COTL1 gene identified by proteomic approach and their association with autoimmune disorders. Exp. Mol. Med. 41: 354-361.
DOI
|
48 |
Sekigawa, I., M. Yanagida, K. Iwabuchi, K. Kaneda, H. Kaneko, Y. Takasaki, G. Jung, S. Sone, Y. Tanaka, H. Ogawa, and K. Takamori. 2008. Protein biomarker analysis by mass spectrometry in patients with rheumatoid arthritis receiving anti-tumor necrosis factor-alpha antibody therapy. Clin. Exp. Rheumatol. 26: 261-267.
|
49 |
Sellam, J., S. Marion-Thore, F. Dumont, S. Jacques, H. J. Garchon, S. Rouanet, Y. Taoufik, H. Hendel-Chavez, J. Sibilia, J. Tebib, L. Le, X, B. Combe, M. Dougados, X. Mariette, and G. Chiocchia. 2014. Use of whole-blood transcriptomic profiling to highlight several pathophysiologic pathways associated with response to rituximab in patients with rheumatoid arthritis: data from a randomized, controlled, open-label trial. Arthritis Rheumatol. 66: 2015-2025.
DOI
|
50 |
Zheng, X., S. L. Wu, M. Hincapie, and W. S. Hancock. 2009. Study of the human plasma proteome of rheumatoid arthritis. J. Chromatogr. A 1216: 3538-3545.
DOI
|
51 |
Kastrinaki, M. C., P. Sidiropoulos, S. Roche, J. Ringe, S. Lehmann, H. Kritikos, V. M. Vlahava, B. Delorme, G. D. Eliopoulos, C. Jorgensen, P. Charbord, T. Haupl, D. T. Boumpas, and H. A. Papadaki. 2008. Functional, molecular and proteomic characterisation of bone marrow mesenchymal stem cells in rheumatoid arthritis. Ann. Rheum. Dis. 67: 741-749.
DOI
|
52 |
Bo, G. P., L. N. Zhou, W. F. He, G. X. Luo, X. F. Jia, C. J. Gan, G. X. Chen, Y. F. Fang, P. M. Larsen, and J. Wu. 2009. Analyses of differential proteome of human synovial fibroblasts obtained from arthritis. Clin. Rheumatol. 28: 191-199.
DOI
|
53 |
Dotzlaw, H., M. Schulz, M. Eggert, and G. Neeck. 2004. A pattern of protein expression in peripheral blood mononuclear cells distinguishes rheumatoid arthritis patients from healthy individuals. Biochim. Biophys. Acta 1696: 121-129.
DOI
|
54 |
Aebersold, R., and M. Mann. 2003. Mass spectrometry-based proteomics. Nature 422: 198-207.
DOI
|
55 |
Angel, T. E., U. K. Aryal, S. M. Hengel, E. S. Baker, R. T. Kelly, E. W. Robinson, and R. D. Smith. 2012. Mass spectrometry-based proteomics: existing capabilities and future directions. Chem. Soc. Rev. 41: 3912-3928.
DOI
|
56 |
Zhang, H., L. Y. Fan, M. Zong, L. S. Sun, and L. Lu. 2012. Proteins related to the functions of fibroblast-like synoviocytes identified by proteomic analysis. Clin. Exp. Rheumatol. 30: 213-221.
|
57 |
Giusti, L., C. Baldini, F. Ciregia, G. Giannaccini, C. Giacomelli, F. F. De, S. A. Delle, L. Riente, A. Lucacchini, L. Bazzichi, and S. Bombardieri. 2010. Is GRP78/BiP a potential salivary biomarker in patients with rheumatoid arthritis? Proteomics Clin. Appl. 4: 315-324.
DOI
|
58 |
Aletaha, D., T. Neogi, A. J. Silman, J. Funovits, D. T. Felson, C. O. Bingham, III, N. S. Birnbaum, G. R. Burmester, V. P. Bykerk, M. D. Cohen, B. Combe, K. H. Costenbader, M. Dougados, P. Emery, G. Ferraccioli, J. M. Hazes, K. Hobbs, T. W. Huizinga, A. Kavanaugh, J. Kay, T. K. Kvien, T. Laing, P. Mease, H. A. Menard, L. W. Moreland, R. L. Naden, T. Pincus, J. S. Smolen, E. Stanislawska-Biernat, D. Symmons, P. P. Tak, K. S. Upchurch, J. Vencovsky, F. Wolfe, and G. Hawker. 2010. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 62: 2569-2581.
DOI
|
59 |
Combe, B., R. Landewe, C. Lukas, H. D. Bolosiu, F. Breedveld, M. Dougados, P. Emery, G. Ferraccioli, J. M. Hazes, L. Klareskog, K. Machold, E. Martin-Mola, H. Nielsen, A. Silman, J. Smolen, and H. Yazici. 2007. EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).Ann. Rheum. Dis. 66: 34-45.
|
60 |
Haraoui, B., J. S. Smolen, D. Aletaha, F. C. Breedveld, G. Burmester, C. Codreanu, J. P. Da Silva, W. M. de, M. Dougados, P. Durez, P. Emery, J. E. Fonseca, A. Gibofsky, J. Gomez-Reino, W. Graninger, V. Hamuryudan, M. J. Jannaut Pena, J. Kalden, T. K. Kvien, I. Laurindo, E. Martin-Mola, C. Montecucco, M. P. Santos, K. Pavelka, G. Poor, M. H. Cardiel, E. Stanislawska-Biernat, T. Takeuchi, and D. van der Heijde. 2011. Treating Rheumatoid Arthritis to Target: multinational recommendations assessment questionnaire. Ann. Rheum. Dis. 70: 1999-2002.
DOI
|